4/22
10:56 am
oprx
Down -18.75% in 4 Weeks, Here's Why You Should You Buy the Dip in OptimizeRx (OPRX) [Yahoo! Finance]
Low
Report
Down -18.75% in 4 Weeks, Here's Why You Should You Buy the Dip in OptimizeRx (OPRX) [Yahoo! Finance]
4/18
07:38 am
oprx
OptimizeRx Releases 2024 Environmental, Social, and Governance (ESG) Report [Yahoo! Finance]
Low
Report
OptimizeRx Releases 2024 Environmental, Social, and Governance (ESG) Report [Yahoo! Finance]
4/18
07:30 am
oprx
OptimizeRx Releases 2024 Environmental, Social, and Governance (ESG) Report
Low
Report
OptimizeRx Releases 2024 Environmental, Social, and Governance (ESG) Report
4/16
12:02 pm
oprx
OptimizeRx Co. (NASDAQ: OPRX) had its "market outperform" rating re-affirmed by analysts at JMP Securities. They now have a $15.00 price target on the stock.
Low
Report
OptimizeRx Co. (NASDAQ: OPRX) had its "market outperform" rating re-affirmed by analysts at JMP Securities. They now have a $15.00 price target on the stock.
4/16
07:19 am
oprx
OptimizeRx Reports Strong Fourth Quarter and Full Year 2023 Financial Results [Yahoo! Finance]
Medium
Report
OptimizeRx Reports Strong Fourth Quarter and Full Year 2023 Financial Results [Yahoo! Finance]
4/16
07:00 am
oprx
OptimizeRx Reports Strong Fourth Quarter and Full Year 2023 Financial Results
Low
Report
OptimizeRx Reports Strong Fourth Quarter and Full Year 2023 Financial Results
4/11
07:40 am
oprx
OptimizeRx Named America's Fastest-Growing Company for Fifth Year in a Row [Yahoo! Finance]
Medium
Report
OptimizeRx Named America's Fastest-Growing Company for Fifth Year in a Row [Yahoo! Finance]
4/11
07:30 am
oprx
OptimizeRx Named America’s Fastest-Growing Company for Fifth Year in a Row
Low
Report
OptimizeRx Named America’s Fastest-Growing Company for Fifth Year in a Row
4/4
08:04 am
oprx
OptimizeRx Co. (NASDAQ: OPRX) is now covered by analysts at JMP Securities. They set a "market outperform" rating and a $15.00 price target on the stock.
Low
Report
OptimizeRx Co. (NASDAQ: OPRX) is now covered by analysts at JMP Securities. They set a "market outperform" rating and a $15.00 price target on the stock.
4/1
03:13 pm
oprx
OptimizeRx Corporation (NASDAQ:OPRX) Q4 2023 Earnings Call Transcript [Yahoo! Finance]
Low
Report
OptimizeRx Corporation (NASDAQ:OPRX) Q4 2023 Earnings Call Transcript [Yahoo! Finance]
4/1
12:17 pm
oprx
OptimizeRx Co. (NASDAQ: OPRX) had its "buy" rating re-affirmed by analysts at Stifel Nicolaus. They now have a $13.00 price target on the stock.
Low
Report
OptimizeRx Co. (NASDAQ: OPRX) had its "buy" rating re-affirmed by analysts at Stifel Nicolaus. They now have a $13.00 price target on the stock.
4/1
10:15 am
oprx
OptimizeRx Co. (NASDAQ: OPRX) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $17.00 price target on the stock.
Low
Report
OptimizeRx Co. (NASDAQ: OPRX) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $17.00 price target on the stock.
3/27
01:53 pm
oprx
OptimizeRx Q4 2023 Earnings Preview [Seeking Alpha]
Low
Report
OptimizeRx Q4 2023 Earnings Preview [Seeking Alpha]
3/25
07:45 am
oprx
OptimizeRx Sets Fourth Quarter 2023 Conference Call for March 28, 2024 at 8:30 a.m. ET [Yahoo! Finance]
Low
Report
OptimizeRx Sets Fourth Quarter 2023 Conference Call for March 28, 2024 at 8:30 a.m. ET [Yahoo! Finance]
3/25
07:30 am
oprx
OptimizeRx Sets Fourth Quarter 2023 Conference Call for March 28, 2024 at 8:30 a.m. ET
Low
Report
OptimizeRx Sets Fourth Quarter 2023 Conference Call for March 28, 2024 at 8:30 a.m. ET
3/22
07:52 pm
oprx
OptimizeRx: Exponential Growth Drives The Valuation Cheaper [Seeking Alpha]
Low
Report
OptimizeRx: Exponential Growth Drives The Valuation Cheaper [Seeking Alpha]
3/11
04:42 pm
oprx
OptimizeRx Provides an Update on the Timing of Earnings Call and Reaffirms Prior Revenue and Adjusted EBITDA Estimates for FY2023 [Yahoo! Finance]
High
Report
OptimizeRx Provides an Update on the Timing of Earnings Call and Reaffirms Prior Revenue and Adjusted EBITDA Estimates for FY2023 [Yahoo! Finance]
3/11
04:30 pm
oprx
OptimizeRx Provides an Update on the Timing of Earnings Call and Reaffirms Prior Revenue and Adjusted EBITDA Estimates for FY2023
High
Report
OptimizeRx Provides an Update on the Timing of Earnings Call and Reaffirms Prior Revenue and Adjusted EBITDA Estimates for FY2023
3/4
03:54 pm
oprx
OptimizeRx Powers Walmart's ‘Specialty Pharmacies of the Community' Outreach Effort [Yahoo! Finance]
Low
Report
OptimizeRx Powers Walmart's ‘Specialty Pharmacies of the Community' Outreach Effort [Yahoo! Finance]
3/4
03:51 pm
oprx
OptimizeRx Powers Walmart's ‘Specialty Pharmacies of the Community’ Outreach Effort
Low
Report
OptimizeRx Powers Walmart's ‘Specialty Pharmacies of the Community’ Outreach Effort
2/21
07:45 am
oprx
OptimizeRx to Participate in Upcoming Investor Conferences [Yahoo! Finance]
Low
Report
OptimizeRx to Participate in Upcoming Investor Conferences [Yahoo! Finance]
2/21
07:30 am
oprx
OptimizeRx to Participate in Upcoming Investor Conferences
Low
Report
OptimizeRx to Participate in Upcoming Investor Conferences